2023年度肿瘤学科基金项目申请和评审工作综述  

Review of the Application Evaluation in Oncology of Department of Health Sciences of National Natural Science Foundation of China in 2023

作　　者：张占国 李璞 王建波 邢晓芳[1,4] 温韬 张卫杰 姚刚[1] 石嵘 Zhanguo Zhang;Pu Li;Jianbo Wang;Xiaofang Xing;Tao Wen;Weijie Zhang;Gang Yao;Rong Shi(Department of Health Sciences,National Natural Science Foundation of China,Beijing 100085;Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030;Qilu Hospital,Shandong University,Jinan 250012;Peking Cancer Hospital,Beijing,China 100142;Beijing Chao-Yang Hospital,Capital Medical University,Beijing 100020)

机构地区：[1]国家自然科学基金委员会医学科学部,北京100085 [2]华中科技大学同济医学院附属同济医院,武汉430030 [3]山东大学附属齐鲁医院,济南250012 [4]北京大学肿瘤医院,北京100142 [5]首都医科大学附属北京朝阳医院,北京100020

出　　处：《中国科学基金》2024年第1期81-85,共5页Bulletin of National Natural Science Foundation of China

摘　　要：2023年国家自然科学基金的各项评审工作已经结束,本文梳理了2023年度医学科学部七处(以下简称“医学七处”)基金项目受理和评审情况,有助于肿瘤学科领域科研工作者对医学七处资助领域的总体情况有所了解,并为2024年度拟在医学七处申报项目的申请人提供参考。The evaluation of applications of the National Natural Science Foundation of China(NSFC)in 2023 has been basically completed,and now we would like to give a brief overview of the evaluation of the applications in Oncology,so that researchers of oncology can have a better understanding of the overall situation of the division VII of the Department of Health Sciences,and hopefully provide reference for the applicants who intend to apply grants of Oncology in the year of 2024.

关 键 词：国家自然科学基金 医学科学 肿瘤学科 评审工作 综述 

分 类 号：R-05[医药卫生] N12[自然科学总论]